Gaudium IVF and Women Health Ltd. is set to launch an Initial Public Offering (IPO) aiming to raise between ₹150 crore and ₹200 crore, with the offering expected to open on February 20, 2026. The capital infusion is primarily earmarked for establishing 19 new IVF centers across India, alongside debt reduction and general corporate purposes. This move positions Gaudium IVF as a pioneer in the assisted reproductive technology (ART) sector tapping public markets. The company reported revenues of ₹70.72 crore and a profit after tax of ₹19.13 crore for the fiscal year ending March 31, 2025. The ART sector in India is projected for substantial growth, driven by increasing infertility rates and rising awareness.